Cite
MLA Citation
Maria Tafelmeier et al.. “Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy.” Clinical cardiology, vol. 43, no. 5, 2020, pp. 430–440. http://access.bl.uk/ark:/81055/vdc_100102729068.0x000053